|
Species | Model | Main findings | Authors |
|
C57BL/6J mice | Transient MCAO (90 minutes) | Splenic atrophy; an increased percentage of FoxP3+CD4+ Tregs in blood and spleen | Offner et al. (2006) [89] |
|
C57/BL6 mice | Transient MCAO (60 minutes) | Accumulation of FoxP3+ lymphocytes in the ischemic hemisphere; a high percentage of FoxP3+CD4+ and FoxP3+CD8+ lymphocytes in splenic T-lymphocytes | Gelderblom et al. (2009) [76] |
|
C57BL/6 mice; Rag1−/− mice; IL-10 knockout mice | Transient MCAO (30 minutes or 90 minutes) | Neuroprotective effects of FoxP3+CD25+CD4+ Tregs: inhibit inflammatory brain damage, restrain secondary infarct expansion, and attenuate functional neurological deficit; IL-10 signal pathway is essential for their immunomodulatory effect | Liesz et al. (2009) [12] |
|
46 consecutive acute stroke patients | Clinical study | Increased apoptosis and a decline of FoxP3+CD25+CD4+ Tregs poststroke; decreased FoxP3+CD25+CD4+ Tregs did not show a correlation with the development of infection or stroke outcome | Urra et al. (2009) [78] |
|
67 subjects (25 of them with acute ischemic stroke) | Clinical study | Increased number of CD25+CD4+ Tregs in the peripheral blood | Yan et al. (2009) [77] |
|
CB-17 mice; SCID mice | Permanent MCAO | Deleption of CD25+ T cells suppressed generation of neural stem/progenitor cells and impaired functional recovery | Saino et al. (2010) [90] |
|
C57BL/6 mice; 22 patients with acute ischemic stroke | Transient MCAO (90 minutes); an ex vivo analysis | The suppressive effect of Tregs in the mouse and humans is unaltered poststroke and reduced efficacy of circulating costimulatory cells after MCAO | Hug et al. (2011) [81] |
|
FoxP3DTR mice | Transient MCAO (60 minutes) | FoxP3+CD4+ Tregs depletion did not affect stroke infarct volume | Ren et al. (2011) [27] |
|
700 subjects | Clinical study | No correlation between low levels of circulating FoxP3+CD25+CD4+ Tregs and an increased risk for the development of stroke | Wigren et al. (2012) [82] |
|
Sprague-Dawley rats | Transient MCAO (120 minutes) | Adoptively transferred CD25+CD4+ Tregs ameliorated neuroinflammation, reduced brain infarct, and improved both short- and long-term neurological functions after cerebral ischemia; CD25+CD4+ Tregs reduce brain infarct size via BBB protection involving inhibition of neutrophil-derived MMP-9 production | Li et al. (2013) [64] |
|
DEREG mice; C57BL/6 wild-type mice; Rag1−/− mice | Transient MCAO (30 minutes or 60 minutes) | FoxP3+CD25+CD4+ Tregs strongly promoted acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature; established immunoregulatory effects of FoxP3+CD4+ Tregs had no functional relevance | Kleinschnitz et al. (2013) [28] |
|
FoxP3EGFP reporter mice; RAG1−/− mice; C57BL/6J mice | Transient MCAO (30 minutes) | A strong accumulation and proliferation of FoxP3+CD25+CD4+ Tregs in the ischemic hemisphere in late phase (peaked around days 14 and up to days 30); delayed depletion of CD25+ Tregs does not worsen long-term outcome | Stubbe et al. (2013) [80] |
|